Epidemiology of prediabetes and diabetes in Namibia, Africa: A multilevel analysis;非洲纳米比亚糖尿病前期与糖尿病的流行病学:一项多层面分析

Journal of Diabetes

Volumn 11, Issue 2, 2019, Pages 161-172

  Adekanmbi, Victor T ^a   Uthman, Olalekan A ^b,c   Erqou, Sebhat ^d   Echouffo Tcheugui, Justin B ^e   Harhay, Meera N ^f,g   Harhay, Michael O ^h  

^a CARDIFF UNIVERSITY SCHOOL OF MEDICINE   (United Kingdom)

^b UNIVERSITY OF WARWICK   (United Kingdom)

^c LIVERPOOL SCHOOL OF TROPICAL MEDICINE   (United Kingdom)

^d BROWN UNIVERSITY   (United States)

^e HARVARD MEDICAL SCHOOL   (United States)

^f DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^g DREXEL UNIVERSITY   (United States)

^h UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

community factors; diabetes; multilevel analysis; Namibia; socioeconomic status

Indexed keywords

ADULT; AGE; ARTICLE; BODY MASS; CLINICAL FEATURE; CORRELATIONAL STUDY; DIABETES MELLITUS; DIABETIC COMPLICATION; DISEASE ASSOCIATION; DISEASE EXACERBATION; FEMALE; HOUSEHOLD; HUMAN; IMPAIRED GLUCOSE TOLERANCE; MAJOR CLINICAL STUDY; MALE; NAMIBIA; NAMIBIAN; OCCUPATION; POPULATION RISK; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; SEX DIFFERENCE; BLOOD; DIET RESTRICTION; GLUCOSE BLOOD LEVEL; HEALTH SURVEY; METABOLISM; MIDDLE AGED; MULTILEVEL ANALYSIS; MULTIVARIATE ANALYSIS; PROCEDURES; STATISTICAL MODEL; STATISTICS AND NUMERICAL DATA;

ADULT; BLOOD GLUCOSE; DIABETES MELLITUS; FASTING; FEMALE; HEALTH SURVEYS; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTILEVEL ANALYSIS; MULTIVARIATE ANALYSIS; NAMIBIA; PREDIABETIC STATE; PREVALENCE;

EID: 85052819768     PISSN: 17530393     EISSN: 17530407     Source Type: Journal    
DOI: 10.1111/1753-0407.12829     Document Type: Article

References (50)

1. Global Burden of Metabolic Risk Factors for Chronic Diseases Collaborators. Cardiovascular disease, chronic kidney disease, and diabetes mortality burden of cardiometabolic risk factors from 1980 to 2010: A comparative risk assessment. Lancet Diabetes Endocrinol. 2014; 2: 634–647
2. Seuring T, Archangelidi O, Suhrcke M. The economic costs of type 2 diabetes: A global systematic review. Pharmacoeconomics. 2015; 33: 811–831
3. Kengne AP, Echouffo-Tcheugui JB, Sobngwi E, Mbanya C. New insights on diabetes mellitus and obesity in Africa–part 1: Prevalence, pathogenesis and comorbidities. Heart. 2013; 99: 979–983
4. NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in diabetes since 1980: A pooled analysis of 751 population-based studies with 4.4 million participants. Lancet. 2016; 387: 1513–1530
5. GBD 2015 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990–2015: A systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016; 388: 1545–1602
6. GBD 2015 Mortality and Causes of Death Collaborators. Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: A systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016; 388: 1459–1544
7. Hall V, Thomsen RW, Henriksen O, Lohse N. Diabetes in Sub Saharan Africa 1999–2011: Epidemiology and public health implications. A systematic review. BMC Public Health. 2011; 11: 564
8. Atun R, Davies JI, Gale EAM et al. Diabetes in sub-Saharan Africa: From clinical care to health policy. Lancet Diabetes Endocrinol. 2017; 5: 622–667
9. Werfalli M, Engel ME, Musekiwa A, Kengne AP, Levitt NS. The prevalence of type 2 diabetes among older people in Africa: A systematic review. Lancet Diabetes Endocrinol. 2016; 4: 72–84
10. Idemyor V. Diabetes in sub-Saharan Africa: Health care perspectives, challenges, and the economic burden of disease. J Natl Med Assoc. 2010; 102: 650–653
11. Mbanya JC, Motala AA, Sobngwi E, Assah FK, Enoru ST. Diabetes in sub-Saharan Africa. Lancet. 2010; 375: 2254–2266
12. Gill GV, Mbanya JC, Ramaiya KL, Tesfaye S. A sub-Saharan African perspective of diabetes. Diabetologia. 2009; 52: 8–16
13. Manne-Goehler J, Atun R, Stokes A et al. Diabetes diagnosis and care in sub-Saharan Africa: Pooled analysis of individual data from 12 countries. Lancet Diabetes Endocrinol. 2016; 4: 903–912
14. Global Burden of Disease Study 2013 Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990–2013: A systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2015; 386: 743–800
15. GBD 2013 Mortality and Causes of Death Collaborators. Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: A systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2015; 385: 117–171
16. World Bank. Namibia Overview. 2015. Available from: http://www.worldbank.org/en/country/namibia/overview (accessed 27 April 2015)
17. Nambia Ministry of Health and Social Services (MoHSS), ICF International. Namibia Demographic and Health Survey 2013. 2014. Available from: https://dhsprogram.com/pubs/pdf/fr298/fr298.pdf (accessed 3 August 2018)
18. World Health Organization (WHO). Definition and Diagnosis of Diabetes Mellitus and Intermediate Hyperglycemia: Report of a WHO/IDF Consultation. WHO, Geneva, 2006
19. Sacks DB, Arnold M, Bakris GL et al. Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus. Clin Chem. 2011; 57: e1–e47
20. American Diabetes Association (ADA). Standards of medical care in diabetes–2015: Summary of revisions. Diabetes Care. 2015; 38 (Suppl): S4
21. Lynch J. A life course approach to chronic disease epidemiology. Annu Rev Public Health. 2005; 26: 1–35
22. Loucks EB, Lynch JW, Pilote L et al. Life-course socioeconomic position and incidence of coronary heart disease. Am J Epidemiol. 2009; 169: 829–836
23. Rutstein S. The DHS Wealth Index. Calverton, ORC Macro, 2004
24. Rutstein S. The DHS Wealth Index: Approaches for Rural and Urban Areas, 2008. Calverton, Macro International, 2008
25. O'Donnell O, van Doorslaer E, Wagstaff A, Lindelow M. Analyzing Health Equity Using Household Survey Data: A Guide to Techniques and Their Implementation. 2008. World Bank. Available from: https://openknowledge.worldbank.org/handle/10986/6896 (accessed 3 August 2018)
26. Vyas S, Kumaranayake L. Constructing socio-economic status indices: How to use principal components analysis. Health Policy Plan. 2006; 21: 459–468
27. Filmer D, Pritchett LH. Estimating wealth effects without expenditure data–or tears: An application to educational enrollments in states of India. Demography. 2001; 38: 115–132
28. Rabe-Hesketh J, Skrondal A. Multilevel and Longitudinal Modeling Using Stata, 3rd edn. Stata Press, College Station, TX, 2012
29. Merlo J, Chaix B, Yang M, Lynch J, Rastam L. A brief conceptual tutorial of multilevel analysis in social epidemiology: Linking the statistical concept of clustering to the idea of contextual phenomenon. J Epidemiol Community Health. 2005; 59: 443–449
30. Merlo J, Yang M, Chaix B, Lynch J, Rastam L. A brief conceptual tutorial on multilevel analysis in social epidemiology: Investigating contextual phenomena in different groups of people. J Epidemiol Community Health. 2005; 59: 729–736
31. Snijders T, Bosker R. Multilevel Analysis–An Introduction to Basic and Advanced Multilevel Modelling. Sage Publications, Thousand Oaks, CA, 1999
32. Rasbash J, Steele F, Browne WJ, Goldstein J. A User's Guide to MLwiN. Version 2.36. University of Bristol, Bristol, 2016
33. Niba LL, Aulinger B, Mbacham WF, Parhofer KG. Predictors of glucose control in children and adolescents with type 1 diabetes: Results of a cross-sectional study in Cameroon. BMC Res Notes. 2017; 10: 207
34. Sundufu AJ, Bockarie CN, Jacobsen KH. The prevalence of type 2 diabetes in urban Bo, Sierra Leone, and in the 16 countries of the West Africa region. Diabetes Metab Res Rev. 2017; 33: e2904
35. Smyth S, Heron A. Diabetes and obesity: The twin epidemics. Nat Med. 2006; 12: 75–80
36. Patel SA, Ali MK, Alam D et al. Obesity and its relation with diabetes and hypertension: A cross-sectional study across four low- and middle-income country regions. Global Heart. 2016; 11: 71–79.e4
37. NCD Risk Factor Collaboration (NCD-RisC) – Africa Working Group. Trends in obesity and diabetes across Africa from 1980 to 2014: An analysis of pooled population-based studies. Int J Epidemiol. 2017; 46: 1421–1432
38. Nsakashalo-Senkwe M, Siziya S, Goma FM, Songolo P, Mukonka V, Babaniyi O. Combined prevalence of impaired glucose level or diabetes and its correlates in Lusaka urban district, Zambia: A population based survey. Int Arch Med. 2011; 4: 2
39. Sartorius B, Sartorius K, Taylor M et al. Rapidly increasing body mass index among children, adolescents and young adults in a transitioning population, South Africa, 2008–15. Int J Epidemiol. 2017; 47: 942–952
40. Addo J, Agyemang C, de-Graft Aikins A et al. Association between socioeconomic position and the prevalence of type 2 diabetes in Ghanaians in different geographic locations: The RODAM study. J Epidemiol Community Health. 2017; 71: 633–639
41. Price AJ, Crampin AC, Amberbir A et al. Prevalence of obesity, hypertension, and diabetes, and cascade of care in sub-Saharan Africa: A cross-sectional, population-based study in rural and urban Malawi. Lancet Diabetes Endocrinol. 2018; 6: 208–222
42. NCD Risk Factor Collaboration (NCD-RisC). Effects of diabetes definition on global surveillance of diabetes prevalence and diagnosis: A pooled analysis of 96 population-based studies with 331,288 participants. Lancet Diabetes Endocrinol. 2015; 3: 624–637
43. Bonora E, Tuomilehto J. The pros and cons of diagnosing diabetes with A1C. Diabetes Care. 2011; 34 (Suppl. 2): S184–S190
44. Sacks DB. A1C versus glucose testing: A comparison. Diabetes Care. 2011; 34: 518–523
45. Chung JKO, Xue H, Pang EWH, Tam DCC. Accuracy of fasting plasma glucose and hemoglobin A1c testing for the early detection of diabetes: A pilot study. Front Lab Med. 2017; 1: 76–81
46. Mayega RW, Guwatudde D, Makumbi FE et al. Comparison of fasting plasma glucose and haemoglobin A1c point-of-care tests in screening for diabetes and abnormal glucose regulation in a rural low income setting. Diabetes Res Clin Pract. 2014; 104: 112–120
47. Khalafallah A, Phuah E, Al-Barazan AM et al. Glycosylated haemoglobin for screening and diagnosis of gestational diabetes mellitus. BMJ Open. 2016; 6: e011059
48. Bullard KM, Saydah SH, Imperatore G et al. Secular changes in U.S. prediabetes prevalence defined by hemoglobin A1c and fasting plasma glucose: National Health and Nutrition Examination Surveys, 1999–2010. Diabetes Care. 2013; 36: 2286–2293
49. Anjana RM, Pradeepa R, Deepa M et al. The Indian Council of Medical Research-India diabetes (ICMR-INDIAB) study: Methodological details. J Diabetes Sci Technol. 2011; 5: 906–914
50. Ali MK, Echouffo-Tcheugui J, Williamson DF. How effective were lifestyle interventions in real-world settings that were modeled on the diabetes prevention program? Health Aff (Millwood). 2012; 31: 67–75